Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
| Image |  |
|---|---|
| Description | scientific article published on 20 June 2008 |
| Author/s |
author: Jane L. Liesveld Camille N. Abboud |
| Publication date | June 20, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |